AGM/EGMJun 5, 2026, 06:07 AM
Addex Therapeutics Convenes 2026 Annual General Meeting
AI Summary
Addex Therapeutics announced its 2026 Annual General Meeting (AGM) will take place on Monday, June 29, 2026, in Geneva. The agenda includes the approval of the 2025 Annual Report, financial statements, and a consultative vote on the 2025 Compensation Report. Shareholders will also vote on the re-election of the Board of Directors, including Chairman Vincent Lawton, and the re-election of the Auditor. Key proposals include amendments to the Articles of Association to increase the capital band and conditional share capital, and the approval of compensation for the Board and Executive Management.
Key Highlights
- Addex Therapeutics to hold its 2026 Annual General Meeting on June 29, 2026, at 11:00 am CEST in Geneva.
- Agenda includes approval of 2025 Annual Report, Financial Statements, and Compensation Report.
- Shareholders will vote on the re-election of Vincent Lawton as Chairman and other Board members.
- Re-election of Compensation Committee members and the Auditor is also on the agenda.
- Proposed amendments to the Articles of Association include increasing the capital band and conditional share capital.
- Approval of compensation for the Board of Directors and Executive Management will be sought.
Price Impact
More from ADXN